000 01317 a2200349 4500
005 20250515080419.0
264 0 _c20070906
008 200709s 0 0 eng d
022 _a1744-7666
024 7 _a10.1517/14656566.8.12.1985
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPfützner, Andreas
245 0 0 _aPioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cAug 2007
300 _a1985-98 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAtherosclerosis
_xprevention & control
650 0 4 _aCardiovascular Diseases
_xdrug therapy
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFatty Liver
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadverse effects
650 0 4 _aPPAR gamma
_xagonists
650 0 4 _aPioglitazone
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aThiazolidinediones
_xadverse effects
700 1 _aWeber, Matthias M
700 1 _aForst, Thomas
773 0 _tExpert opinion on pharmacotherapy
_gvol. 8
_gno. 12
_gp. 1985-98
856 4 0 _uhttps://doi.org/10.1517/14656566.8.12.1985
_zAvailable from publisher's website
999 _c17228346
_d17228346